Intermittent fasting protects β-cell identity and function in a type-2 diabetes model
- PMID: 38307325
- PMCID: PMC10985623
- DOI: 10.1016/j.metabol.2024.155813
Intermittent fasting protects β-cell identity and function in a type-2 diabetes model
Abstract
Type 2 diabetes (T2DM) is caused by the interaction of multiple genes and environmental factors. T2DM is characterized by hyperglycemia, insulin secretion deficiency and insulin resistance. Chronic hyperglycemia induces β-cell dysfunction, loss of β-cell mass/identity and β-cell dedifferentiation. Intermittent fasting (IF) a commonly used dietary regimen for weight-loss, also induces metabolic benefits including reduced blood glucose, improved insulin sensitivity, reduced adiposity, inflammation, oxidative-stress and increased fatty-acid oxidation; however, the mechanisms underlying these effects in pancreatic β-cells remain elusive. KK and KKAy, mouse models of polygenic T2DM spontaneously develop hyperglycemia, glucose intolerance, glucosuria, impaired insulin secretion and insulin resistance. To determine the long-term effects of IF on T2DM, 6-weeks old KK and KKAy mice were subjected to IF for 16 weeks. While KKAy mice fed ad-libitum demonstrated severe hyperglycemia (460 mg/dL) at 6 weeks of age, KK mice showed blood glucose levels of 230 mg/dL, but progressively became severely diabetic by 22-weeks. Strikingly, both KK and KKAy mice subjected to IF showed reduced blood glucose and plasma insulin levels, decreased body weight gain, reduced plasma triglycerides and cholesterol, and improved insulin sensitivity. They also demonstrated enhanced expression of the β-cell transcription factors NKX6.1, MAFA and PDX1, and decreased expression of ALDH1a3 suggesting protection from loss of β-cell identity by IF. IF normalized glucose stimulated insulin secretion in islets from KK and KKAy mice, demonstrating improved β-cell function. In addition, hepatic steatosis, gluconeogenesis and inflammation was decreased particularly in KKAy-IF mice, indicating peripheral benefits of IF. These results have important implications as an optional intervention for preservation of β-cell identity and function in T2DM.
Keywords: Diabetes; Identity; Insulin; Intermittent fasting; Metabolism; beta-cell.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that no conflict of interest exists. Dr. Maria Remedi is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Similar articles
-
Morus alba L. (Sangzhi) Alkaloids Promote Insulin Secretion, Restore Diabetic β-Cell Function by Preventing Dedifferentiation and Apoptosis.Front Pharmacol. 2022 Mar 3;13:841981. doi: 10.3389/fphar.2022.841981. eCollection 2022. Front Pharmacol. 2022. PMID: 35308210 Free PMC article.
-
Dietary nitrite supplementation improves insulin resistance in type 2 diabetic KKA(y) mice.Nitric Oxide. 2015 Jan 30;44:31-8. doi: 10.1016/j.niox.2014.11.009. Epub 2014 Nov 13. Nitric Oxide. 2015. PMID: 25461271
-
Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.Metabolism. 2012 Jul;61(7):944-53. doi: 10.1016/j.metabol.2011.10.023. Epub 2011 Dec 7. Metabolism. 2012. PMID: 22154323
-
Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.Am J Med. 1985 Aug 23;79(2B):6-12. doi: 10.1016/0002-9343(85)90579-0. Am J Med. 1985. PMID: 2863979 Review.
-
Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.Am J Med. 1991 Jun 24;90(6A):8S-14S. doi: 10.1016/0002-9343(91)90412-q. Am J Med. 1991. PMID: 1872310 Review.
Cited by
-
Enhanced Effects of Intermittent Fasting by Magnetic Fields in Severe Diabetes.Research (Wash D C). 2024 Sep 5;7:0468. doi: 10.34133/research.0468. eCollection 2024. Research (Wash D C). 2024. PMID: 39238846 Free PMC article.
-
Type 2 diabetes microenvironment promotes the development of Parkinson's disease by activating microglial cell inflammation.Front Cell Dev Biol. 2024 Jul 10;12:1422746. doi: 10.3389/fcell.2024.1422746. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39050892 Free PMC article.
-
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.Curr Issues Mol Biol. 2024 Jul 18;46(7):7621-7667. doi: 10.3390/cimb46070453. Curr Issues Mol Biol. 2024. PMID: 39057094 Free PMC article. Review.
-
Loss of β-cell identity and dedifferentiation, not an irreversible process?Front Endocrinol (Lausanne). 2024 Jun 10;15:1414447. doi: 10.3389/fendo.2024.1414447. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38915897 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
